Mortality rates increased 1.8 percent for uterine cancer overall, 2.7 percent for nonendometrioid carcinoma<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, May 6, 2022 (HealthDay News) — Uterine cancer mortality increased from 2010 to 2017, with larger increases seen for nonendometrioid uterine carcinoma, according to a study published online May 5 in JAMA Oncology<\/em>.<\/p>\n Megan A. Clarke, Ph.D., from the National Cancer Institute in Rockville, Maryland, and colleagues estimated histologic subtype- and stage-specific uterine cancer mortality rates by race and ethnicity in a cohort study. Data were included for 208,587 women diagnosed with uterine cancer during 2000 to 2017 (7.7 percent Asian, 9.7 percent Black, 11.1 percent Hispanic, and 71.5 percent White).<\/p>\n The researchers found 16,797 uterine cancer deaths occurred between 2010 and 2017, for a hysterectomy-corrected mortality rate of 15.7 per 100,000 person-years. Overall, by histologic subtype and stage at diagnosis, hysterectomy-corrected rates were highest among Black women. Among all women, there was a significant 1.8 percent annual increase in mortality rates for uterine corpus cancer from 2010 to 2017 and a 2.7 percent increase in mortality rates for nonendometrioid carcinoma; increases were seen in Asian, Black, Hispanic, and White women (3.4, 3.5, 6.7, and 1.5 percent, respectively). Endometrioid carcinoma mortality rates remained stable during the same period.<\/p>\n “Our study suggests racial disparities in uterine cancer mortality that appear to be multifactorial, including a higher incidence of aggressive subtypes and worse outcomes independent of subtype and stage among Black women,” the authors write.<\/p>\n One author disclosed financial ties to several pharmaceutical companies.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n